Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 68Colonic Neoplasms 22Rectal Neoplasms 21Neoplasm Metastasis 18Neoplasms 15Carcinoma, Non-Small-Cell Lung 8Head and Neck Neoplasms 7Esophageal Neoplasms 6Cholangiocarcinoma 6Lung Neoplasms 5Carcinoma, Squamous Cell 5Carcinoma 5Squamous Cell Carcinoma of Head and Neck 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 2Solid Tumors 2Recurrence 2Kidney Neoplasms 2Gastrointestinal Neoplasms 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Solid Tumor, Adult 1Ovarian Neoplasms 1Inflammatory Breast Neoplasms 1Gallbladder Neoplasms 1

Interventions

Cisplatin 2fluoroazomycin arabinoside 1fludarabine phosphate 1fludarabine 1aldesleukin 1Radiotherapy, Intensity-Modulated 1Panitumumab 1Paclitaxel 1Nivolumab 1Metformin 1Interleukin-2 1Fluorouracil 1Docetaxel 1Cyclophosphamide 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Adenosquamous × Panitumumab × Clear all
NCT00513383 2017-03-01

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

Massachusetts General Hospital

Phase 1 Completed
34 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡